SCHEMBL896814

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL897555	0.94	ALK (0.73)	ALKKDRIGF1RSRCABL1
	SCHEMBL897275	0.89	ALK (1.00)	ALK
	SCHEMBL1702995	0.88	ALK (0.80)	ALKKDRIGF1RSRCABL1
	SCHEMBL896921	0.88	ALK (0.77)	ALK
	SCHEMBL7808984	0.88	ALK (0.65)	ALKKDRIGF1RSRCABL1
	SCHEMBL896483	0.87	ALK (0.70)	ALKKDR
	SCHEMBL20004615	0.87	ALK (0.67)	ALKKDRIGF1RSRCABL1
	SCHEMBL897278	0.87	ALK (0.82)	ALK
	SCHEMBL16775674	0.86	ALK (0.66)	ALKKDRIGF1RSRCABL1
	SCHEMBL897993	0.86	ALK (0.74)	ALKKDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.